Conscious Sedation vs General Anesthesia in TAVR Patients
- Conditions
- Aortic Stenosis
- Interventions
- Procedure: General AnesthesiaProcedure: Conscious Sedation
- Registration Number
- NCT03084978
- Lead Sponsor
- Montefiore Medical Center
- Brief Summary
This is a randomized controlled trial investigating the effect of general anesthesia versus conscious sedation on operative times in patients undergoing transcatheter aortic valve replacement.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Signed informed consent, signed Health Insurance Portability and Accountability Act (HIPAA) documentation)
- Age over 18 years of age.
- Women of child bearing age must have a negative urine or serum pregnancy test.
- Clinical indication for a transfemoral aortic valve replacement.
- English or Spanish speaking
- No evidence of neurological impairment as defined by a NIHSS ≤ 1 and modified Rankin scale (mRS) ≤ 2 within 7 days prior to randomization.
- BMI > 40
- Diagnosis of severe obstructive sleep apnea based on previous polysomnography, with severe defined as an apnea-hypopnea index (AHI) >30 episodes/hr.
- High risk for aspiration such as severe esophageal disease (e.g. achalasia, gastroparesis, etc).
- Inability to lie supine for more than 30 minutes.
- Marginal femoral vessels with concern for possible conversion to transapical or transaortic access.
- Patient refusal
- Patient involved in another research study
- Psychiatric condition precluding ability to provide informed consent
- History of clinical stroke within 3 months prior to randomization
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description General Anesthesia General Anesthesia Subjects will undergo general anesthesia with endotracheal intubation. Conscious Sedation Conscious Sedation Subjects will undergo conscious sedation anesthesia.
- Primary Outcome Measures
Name Time Method Time-on-table <1 day * time to patient on table to surgical drapes down
* time to patient on table to when deemed safe for transport by anesthesiologist and surgeon
- Secondary Outcome Measures
Name Time Method Number of patients with serious adverse events within 30 days * deaths
* conversion from sedation to intubation
* hypersensitivity reactionsLength of stay within 30 days * ICU length of stay (days)
* Hospital length of stay (days)Readmissions within 30 days Number of patients readmitted within 30 days of initial procedure
Number of Patients with Valve Complications within 30 days * paravalvular leak on echocardiogram
* pacemaker requirement
* vascular complications requiring reintervention
* post-procedure requiring valve dilationContrast usage <1 day Amount of contrast used in mL for procedure
Fluoroscopy time <1 day Amount of time fluoroscopy used